Sign in

NCT03004326Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Source: ClinicalTrials.gov · Last updated 22 Jan 2026

Brief summary (registry, in English)

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
20 Dec 2016
Start date
1 Jan 2017
Primary completion date
31 Dec 2028
Lead sponsor
Peter Merkel
NCT number
NCT03004326

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 1 Jan 2017 to the primary completion date, 31 Dec 2028
  • 10 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Considered not to be a candidate for a biopsy or have a higher risk of developing an infection, bleeding, etc., from the biopsy, or a doctor believes that the risks for you participating in this study do not outweigh the potential benefit of learning information from your biopsy
  • You have an uncontrolled disease that could prevent you from completing the study procedures
  • You have an active infection at or near the potential biopsy site, have poor circulation, or have bony prominence or other structure that would increase your risk of complications if you participated in this study

Lab values

  • You have a neutrophil count (type of white blood cell) less than 1500/mm3, platelet count less than 50,000/mm3, or a hemoglobin less than 7 g/dL

Age

  • You are less than five years old

Other

  • You are pregnant or nursing
  • You are not able to provide informed consent

Who the study is looking for

  • Have a cutaneous lesion (purpuric macules, palpable purpura, retiform purpura, nodules, ulcers, or urticarial) believed to be related to active vasculitis
  • Have a suspected or confirmed diagnosis of:
    • Cryoglobulinemic vasculitis (CV)
    • Drug-induced vasculitis
    • Eosinophilic granulomatosis with polyangiitis (EGPA)
    • IgA vasculitis
    • Isolated cutaneous vasculitis
    • Granulomatosis with polyangiitis (GPA)
    • Microscopic polyangiitis (MPA)
    • Polyarteritis nodosa (PAN)
    • Urticarial vasculitis
  • Be willing and able to provide written informed consent (or assent for those under

Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
St. Joseph's Healthcare
Coordinator of this site? Confirm its status
HamiltonCanadaRecruiting
University of Toronto Mount Sinai Hospital
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
Boston University School of Medicine
Coordinator of this site? Confirm its status
BostonUnited StatesCompleted
University of Virginia
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesRecruiting
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesCompleted
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesCompleted
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Oregon Health Science University
Coordinator of this site? Confirm its status
PortlandUnited StatesCompleted
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesCompleted
University of Utah
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesCompleted

This page is information, not medical advice. Discuss any trial with your doctor.